According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
Confinement measures extended to April 15th "We are only at the beginning of the epidemic wave. Read More
The French Prime minister has warned this morning that France is settling into a crisis that will last.... Read More
In France, the Minister of Health has authorised, supervised by decree, the prescription of chloroquine for patients with coronavirus. This is now pos... Read More